Forward look has been saved
Top regulatory midyear trends for 2014 in life sciences
The regulatory landscape in life sciences is expected to be increasingly challenging and uncertain. Regulatory authorities continue to increase their compliance, oversight and enforcement activities for existing laws.
Meanwhile, lawmakers and agencies are introducing new rules and requirements that will significantly affect how life sciences companies do business. In this dynamic environment, organizations continue to invest significant time, resources and effort to achieve compliance – even while certain parts of the regulatory environment are still unfolding.
Here is a look at what we believe are six of the most important regulatory trends for the rest of 2014 – and beyond. This is not an exhaustive list, but we think addressing these issues should be at or near the top of the regulatory agenda.
- Patient safety and enforcement
- Increasing emphasis on transparency
- Greater collaboration between regulatory and businesses
- Accelerated product approvals
- Secure supply chain